ETRAVIRINE
Generic: ETRAVIRINE
Bionpharma Inc.Manufacturer
ORALRoute
ETRAVIRINEActive Substance
2025-10-02Original Approval
ETRAVIRINE is FDA application ANDA219152, sponsored by BIONPHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG RESISTANCE
211 reports
2
DRUG INTERACTION
196 reports
3
VIROLOGIC FAILURE
182 reports
4
TREATMENT FAILURE
170 reports
5
VIRAL MUTATION IDENTIFIED
136 reports
6
PATHOGEN RESISTANCE
113 reports
7
DEATH
108 reports
8
LIPODYSTROPHY ACQUIRED
86 reports
9
CD4 LYMPHOCYTES DECREASED
85 reports
10
CD4/CD8 RATIO DECREASED
77 reports